Understanding the role of the novel TLDc proteins in neurodegeneration
Mattéa Finelli is a postdoctoral research assistant in the University of Oxford (Department of Physiology, Anatomy and Genetics) and a Junior Research Fellow at St Edmund Hall in Oxford. She received a M.Sc. in Engineering from SupAgro (Montpellier, France) and a M.Res. in Biomedical Research from Imperial College (London). She completed her D.Phil (2010) in Neurosciences in Prof Dame Kay Davies’ group at the University of Oxford. She then completed a first two-year postdoctoral project at Mount Sinai School of Medicine (New York, NY). She has been working in Prof Peter Oliver’s group at the University of Oxford since 2013.
Date:
15 May 2018, 11:00 (Tuesday, 4th week, Trinity 2018)
Venue:
NDM Building, Headington OX3 7FZ
Venue Details:
Basement Seminar room
Speaker:
Mattea Finelli (University of Oxford)
Organiser:
Dr John Davis (Alzheimer’s Research UK Oxford Drug Discovery Institute)
Organiser contact email address:
keely.jones@ndm.ox.ac.uk
Part of:
ARUK Oxford Drug Discovery Institute Seminar Series
Booking required?:
Not required
Cost:
FREE
Audience:
Public
Editor:
Keely Jones
